Delayed
Toronto S.E.
03:55:54 2023-05-05 pm EDT
|
5-day change
|
1st Jan Change
|
0.02
CAD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
---|
Capitalization
1 |
8
|
205
|
64.36
|
Enterprise Value (EV)
1 |
13.55
|
187.1
|
68.9
|
P/E ratio
|
-0.7
x
|
-13.5
x
|
-4.49
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.6
x
|
15.6
x
|
2.37
x
|
EV / Revenue
|
1.01
x
|
14.2
x
|
2.54
x
|
EV / EBITDA
|
-2,747,459
x
|
-29,933,658
x
|
-3,750,893
x
|
EV / FCF
|
33,495,599
x
|
-777,515,048
x
|
-9,727,367
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
Price to Book
|
5.97
x
|
7.42
x
|
2.04
x
|
Nbr of stocks (in thousands)
|
16,000
|
35,036
|
39,007
|
Reference price
2 |
0.5000
|
5.850
|
1.650
|
Announcement Date
|
6/18/20
|
4/20/21
|
3/30/22
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
1 |
0.0015
|
0.2801
|
10.77
|
13.42
|
13.14
|
27.16
|
EBITDA
|
-
|
-1.15
|
-2.45
|
-4.932
|
-6.25
|
-18.37
|
EBIT
1 |
-0.1526
|
-1.168
|
-2.872
|
-5.493
|
-6.934
|
-20.2
|
Operating Margin
|
-10,176.67%
|
-417.19%
|
-26.67%
|
-40.92%
|
-52.77%
|
-74.39%
|
Earnings before Tax (EBT)
1 |
-0.1534
|
-1.249
|
-3.773
|
-10.86
|
-9.481
|
-22.15
|
Net income
1 |
-0.1534
|
-1.257
|
-3.657
|
-10.97
|
-9.481
|
-13.75
|
Net margin
|
-10,229.67%
|
-448.8%
|
-33.96%
|
-81.75%
|
-72.15%
|
-50.62%
|
EPS
2 |
-0.0394
|
-0.1380
|
-0.3255
|
-0.7108
|
-0.4332
|
-0.3671
|
Free Cash Flow
|
-
|
-0.6108
|
-1.643
|
0.4046
|
-0.2406
|
-7.083
|
FCF margin
|
-
|
-218.1%
|
-15.26%
|
3.01%
|
-1.83%
|
-26.08%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/24/18
|
12/24/18
|
4/30/19
|
6/18/20
|
4/20/21
|
3/30/22
|
Fiscal Period: December |
2020 Q3
|
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
---|
Net sales
1 |
3.31
|
3.199
|
5.174
|
10.51
|
12.2
|
9.91
|
7.713
|
8.724
|
20.85
|
EBITDA
1 |
0.3862
|
-2.147
|
-1.331
|
-1.517
|
-2.594
|
-9.924
|
-6.673
|
-5.426
|
-3.97
|
EBIT
1 |
-0.2157
|
-5.828
|
-2.67
|
-3.496
|
-3.874
|
-10.42
|
-7.581
|
-6.665
|
-5.601
|
Operating Margin
|
-6.52%
|
-182.2%
|
-51.61%
|
-33.25%
|
-31.75%
|
-105.13%
|
-98.29%
|
-76.4%
|
-26.86%
|
Earnings before Tax (EBT)
1 |
-
|
-6.573
|
-2.214
|
-4.212
|
-3.444
|
-12.28
|
-8.303
|
-5.169
|
-4.324
|
Net income
1 |
-
|
-6.573
|
-2.214
|
-4.212
|
-3.444
|
-3.878
|
-8.267
|
-5.29
|
-4.462
|
Net margin
|
-
|
-205.51%
|
-42.79%
|
-40.06%
|
-28.22%
|
-39.13%
|
-107.18%
|
-60.64%
|
-21.4%
|
EPS
2 |
-
|
-0.2850
|
-0.0620
|
-0.1140
|
-0.0900
|
-0.0900
|
-0.2100
|
-0.1300
|
-0.1100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/30/20
|
4/20/21
|
5/31/21
|
8/16/21
|
11/15/21
|
3/30/22
|
5/16/22
|
8/15/22
|
11/16/22
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
-
|
3.03
|
3.82
|
5.55
|
-
|
4.54
|
Net Cash position
1 |
0.04
|
-
|
-
|
-
|
17.9
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-2.64
x
|
-1.56
x
|
-1.125
x
|
-
|
-0.2471
x
|
Free Cash Flow
|
-
|
-0.61
|
-1.64
|
0.4
|
-0.24
|
-7.08
|
ROE (net income / shareholders' equity)
|
-
|
-48.7%
|
-67.5%
|
-303%
|
-65.3%
|
-66.9%
|
ROA (Net income/ Total Assets)
|
-
|
-15.7%
|
-18%
|
-33.7%
|
-21.2%
|
-26.1%
|
Assets
1 |
-
|
7.995
|
20.37
|
32.57
|
44.8
|
52.76
|
Book Value Per Share
2 |
0.0200
|
0.4800
|
0.4600
|
0.0800
|
0.7900
|
0.8100
|
Cash Flow per Share
2 |
0.0100
|
0.1000
|
0.0300
|
0.0100
|
0.5700
|
0.3000
|
Capex
|
-
|
0.02
|
0.24
|
0.07
|
0.03
|
0.13
|
Capex / Sales
|
-
|
7.65%
|
2.24%
|
0.53%
|
0.24%
|
0.49%
|
Announcement Date
|
12/24/18
|
12/24/18
|
4/30/19
|
6/18/20
|
4/20/21
|
3/30/22
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 600K | | +24.66% | 88.38B | | -21.76% | 77.56B | | +1.76% | 26.97B | | +7.94% | 18.45B | | -13.50% | 16.57B | | +3.23% | 15.81B | | +77.51% | 13.65B | | +76.96% | 13.06B | | +23.02% | 12.55B |
Other Healthcare Facilities & Services
|